
Digbi Health Integrates Hormone Therapy and GLP-1 Care into Telehealth Platform
Edited by Vita Solenne
Research & Biotech · Updated October 5, 2026
Digbi Health has expanded its Precision Biology telehealth platform to include clinical hormone replacement therapy alongside GLP-1 care. This integration aims to address obesity, metabolic issues, gastrointestinal health, and inflammation, providing a comprehensive approach to hormonal services. Over 300 employers and health plans are set to offer these new services as part of their existing agreements, with many planning to incorporate them into their 2027 health plans.
Share this story
Why it matters
- ✓Combining hormone therapy with GLP-1 care may provide a more holistic approach to managing health conditions related to obesity and metabolism, which are critical for longevity.
- ✓Access to these integrated services through employers can enhance the health optimization efforts of individuals, making advanced therapies more accessible.
- ✓The focus on hormonal balance and metabolic health aligns with current trends in longevity science, emphasizing the importance of personalized health strategies.
Digbi Health Integrates Hormone Therapy and GLP-1 Care into Telehealth Platform
Overview of Digbi Health's Expansion
Digbi Health, a telehealth platform focused on precision biology, has recently expanded its services to include clinical hormone replacement therapy. This new offering is integrated with GLP-1 care, which is significant for individuals dealing with obesity, metabolic disorders, gastrointestinal issues, and inflammation. The integration of these services into a single app aims to provide a comprehensive solution for patients seeking to optimize their health through hormonal balance and metabolic management.
The Importance of Hormonal Health
Hormones play a crucial role in regulating various bodily functions, including metabolism, mood, and overall health. Hormone replacement therapy (HRT) has been used for decades to treat hormonal imbalances, particularly in women during menopause. By incorporating HRT into their platform, Digbi Health acknowledges the importance of hormonal health in the broader context of longevity and wellness.
GLP-1 (glucagon-like peptide-1) is a hormone that has gained attention for its role in regulating appetite and insulin secretion. Medications that mimic GLP-1 have been shown to aid in weight loss and improve metabolic health, making them an important tool in the management of obesity and related conditions. The combination of HRT and GLP-1 care could provide a synergistic effect, addressing multiple aspects of health that are critical for longevity.
Access and Implementation
Digbi Health's new services will be available to over 300 employers and health plans that currently contract with the company. Many of these organizations are already planning to incorporate the new offerings into their health plans for 2027. This accessibility is particularly noteworthy, as it allows a broader population to benefit from advanced hormonal therapies and metabolic management strategies without the barriers often associated with traditional healthcare systems.
Implications for Longevity Enthusiasts
For those pursuing longevity and health optimization, the integration of hormone therapy and GLP-1 care presents several potential benefits:
-
Holistic Health Management: By addressing hormonal balance alongside metabolic health, individuals can take a more comprehensive approach to their wellness, potentially leading to better health outcomes.
-
Personalized Care: The telehealth model allows for more personalized health strategies, which are essential for effective longevity practices. Patients can receive tailored advice and treatment plans based on their unique health profiles.
-
Increased Accessibility: With employers and health plans adopting these services, more individuals may gain access to cutting-edge therapies that were previously limited to specialized clinics or high-cost treatments.
Conclusion
The expansion of Digbi Health's Precision Biology telehealth platform to include hormone therapy and GLP-1 care marks a significant step in the integration of advanced health management strategies. As more employers and health plans begin to offer these services, individuals pursuing longevity and health optimization will have greater access to tools that can help them achieve their wellness goals. This development aligns with the growing recognition of the importance of hormonal and metabolic health in the quest for a longer, healthier life.
Sources
- Digbi Health combines hormone therapy, GLP-1 care in single app — Longevity Technology
Newsletter
Your weekly longevity signal. No spam.
Comments
Log in with
Loading comments…
More in Biotech

Fractyl Revita Shows Promise in Reducing Weight Regain After GLP-1 Therapy
Fractyl Health has announced positive results from the REMAIN-1 pivotal study, which evaluated the…
Just now

Exploring the Connection Between Big Pharma and Gray-Market Peptides
A recent analysis reveals significant ties between the pharmaceutical industry and gray-market…
2d ago

Kailera Completes Enrollment for Obesity Trials, Results Expected in 2028
Kailera has completed enrollment for its three Phase 3 trials of ribupatide, a weekly injection…
2d ago

Longeveron’s Stem Cell Therapy Shows Promise for Reducing Brain Inflammation in Alzheimer’s Patients
Longeveron has released new preclinical data suggesting that its stem cell therapy may lead to…
2d ago